N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1171-1182

  Rubie, H ^a   Hartmann, O ^a   Michon, J ^a   Frappaz, D ^a   Coze, C ^a   Chastagner, P ^a   Baranzelli, M C ^a   Plantaz, D ^a   Avet Loiseau, H ^a   Benard J ^a   Delattre, O ^a   Favrot, M ^a   Peyroulet, M C ^a   Thyss, A ^a   Perel, Y ^a   Bergeron, C ^a   Courbon Collet, B ^a   Vannier, J P ^a   Lemerle, J ^a   Sommelet, D ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; GENE AMPLIFICATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NEWBORN; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0031049728     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1171     Document Type: Article

References (45)

1. Bernstein ML, Leclerc JM, Bunin G, et al: A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 10:323-329, 1992
2. Hartmann O, Scopinaro M, Tournade ME, et al: Neuroblastomes traités à l'Institut Gustave Roussy de 1975 à 1979. Cent soixante treize cas. Arch Fr Pediatr 40:15-21, 1983
3. Rosen EM, Cassady JR, Frantz CN, et al: Neuroblastoma: The Joint Center for Radiation Therapy/Dana Farber Cancer Institute/ Children's Hospital experience. J Clin Oncol 2:719-732, 1984
4. Berthold F, Brandeis WE, Lampert F: Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr Paediatr 18:206-223, 1986
5. Evans AE, Albo V, D'Angio GJ, et al: Factors influencing survival of children with non metastatic neuroblastoma. Cancer 38:661-666, 1976
6. Le Tourneau JN, Bernard JL, Hendren WH, et al: Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20:244-249, 1985
7. Haase GM, Wong KY, De Lorimier AA, et al: Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194-200, 1989
8. De Bemardi B, Rogers D, Carli M, et al: Localized neuroblastoma. Surgical and pathological staging. Cancer 60:1066-1072, 1987
9. Evans AE, D'Angio GH, Koop C, et al: The role of multimodal therapy in patients with local and regional neuroblastoma. J Pediatr Surg 19:77-80, 1984
10. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of N-Myc oncogene with rapid progression of neuroblastomas. N Engl J Med 318:111-116, 1985
11. Brodeur GM, Azar C, Brother M, et al: Neuroblastoma: Effect of genetic factors on prognosis and treatment. Cancer 70:1685-1694, 1992
12. Zucker JM, Margulis E: Radiochemotherapy of post operative minimal residual disease in neuroblastoma. Recent results. Cancer Res 68:423-430, 1979
13. Ninane J, Pritchard J, Jones PHM, et al: Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438-442, 1982
14. Rosen EM, Cassady JR, Kretschmar C, et al: Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260-263, 1984
15. McGuire WA, Simmons D, Grosfeld JL, et al: Stage II neuroblastoma. Does adjuvant irradiation contribute to cure? Med Pediatr Oncol 13:117-121, 1985
16. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
17. Nitschke R, Smith EI, Altshuler G, et al: Postoperative treatment of nonmetastatic visible residual neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 9:1181-1188, 1991
18. Garaventa A, Guerra P, Arrighini A, et al: Treatment of advanced neuroblastoma with I-131 meta-iodobenzyl-guanidine. Cancer 67:922-928, 1991
19. West DC, Shamberger RC, Macklis RM, et al: Stage III neuroblastoma over 1 year of age at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11:84-90, 1993
20. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
21. Meadows AT: Second malignant neoplasms. Clin Oncol 4:247-261, 1985
22. McEwan AJ, Shapiro B, Sisson JC, et al: Radio-iodobenzyl-guanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 25:132-153, 1985
23. Bertani-Dziedzic L, Dziedzic SW, Gitlow SE: Catecholamine metabolism in neuroblastoma, in Pochedly C (ed): Neuroblastoma: Tumor Biology and Therapy. Boca Raton, FL, CRC, 1990, pp 69-91
24. Zelter PM, Marangos PJ, Evans AE, et al: Serum neuron specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 57:1230-1234, 1986
25. Hahn HWL, Levy HM, Evans AE: Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 40:1411-1413, 1980
26. Shuster JH, McWilliams NB, Castelberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. Am J Clin Oncol 15:295-303, 1992
27. Mäkinen J: Microscopic patterns as a guide to prognosis of neuroblastoma in childhood. Cancer 29:1637-1646, 1972
28. American Joint Committee: Neuroblastoma, in Beahrs OH, Myers MH (eds): Manual of Staging of Cancer. Philadelphia, PA, Lippincott, 1983, pp 237-239
29. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging and Response to Treatment. J Clin Oncol 11:1466-1477, 1993
30. Look AT, Hayes FA, Nitschke R, et al: Cellular DNA content as predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
31. Caron H: In neuroblastoma allelic loss of chromosome 1 p and the presence of additional chromosome 17 q material are both associated with an unfavorable outcome. Twenty-fifth Annual Meeting of the International Society of Pediatric Oncology, San Francisco, CA, October 5-9, 1993
32. Frappaz D, Michon J, Hartmann O, et al: Etoposide and carboplatin in neuroblastoma: A French Society of Pediatric Oncology phase II study. J Clin Oncol 10:1592-1601, 1992
33. Fleiss JI: Statistical Methods for Rates and Proportions (ed 2). New York, NY, Wiley, 1981
34. Peto R, McPherson K, Peto J, et al: Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
35. Cox DR: The Analysis of Binary Data. London, England, Chapman & Hall, 1977
36. Plantaz D, Rubie H, Michon J, et al: The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients. Results of the NBL 90 Study of the French Society of Pediatric Oncology. Cancer 78:311-319, 1996
37. Evans AE, D'Angio GH, Sather HN, et al: A comparison of four staging systems for localized and regional neuroblastoma: A report from the Children's Cancer Study Group. J Clin Oncol 8:678-688, 1990
38. De Bernardi B, Conte M, Mancini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
39. Castel V, Badal MD, Bezanilla JL, et al: Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 24:29-35, 1995
40. Castleberry RP, Kun LE, Shuster JJ, et al: Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9:789-795, 1991
41. Hayes FA, Green AA, O'Connor DM: Chemotherapeutic management of epidural neuroblastoma. Med Pediatr Oncol 17:6-8, 1989
42. Goon HK, Cohen DH, Harvey JG: Review of thoracic neuroblastoma. Aust Paediatr J 20:17-21, 1984
43. Rubie H, Hartmann O, Giron A, et al: Non metastatic thoracic neuroblastomas: A review of 40 cases. Med Pediatr Oncol 19:253-257, 1991
44. Cohn SL, Look AT, Joshi VV, et al: Lack of correlation of N-Myc gene amplification with prognosis in localized neuroblastoma: A Pediatric Oncology Group Study. Cancer Res 55:721-726, 1995
45. Joshi VV, Cantor A, Altshuler G, et al: Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification: A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer 69:2183-2196, 1992